Anti-TNR8/ TNFRSF8/ CD30 monoclonal antibody
Anti-TNR8/ TNFRSF8/ CD30 antibody for FACS & in-vivo assay
Go to TNFRSF8/TNFRSF8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T88023-Ab-1/ GM-Tg-hg-T88023-Ab-2 | Anti-Human TNFRSF8 monoclonal antibody | Human |
GM-Tg-rg-T88023-Ab-1/ GM-Tg-rg-T88023-Ab-2 | Anti-Rat TNFRSF8 monoclonal antibody | Rat |
GM-Tg-mg-T88023-Ab-1/ GM-Tg-mg-T88023-Ab-2 | Anti-Mouse TNFRSF8 monoclonal antibody | Mouse |
GM-Tg-cynog-T88023-Ab-1/ GM-Tg-cynog-T88023-Ab-2 | Anti-Cynomolgus/ Rhesus macaque TNFRSF8 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T88023-Ab-1/ GM-Tg-felg-T88023-Ab-2 | Anti-Feline TNFRSF8 monoclonal antibody | Feline |
GM-Tg-cang-T88023-Ab-1/ GM-Tg-cang-T88023-Ab-2 | Anti-Canine TNFRSF8 monoclonal antibody | Canine |
GM-Tg-bovg-T88023-Ab-1/ GM-Tg-bovg-T88023-Ab-2 | Anti-Bovine TNFRSF8 monoclonal antibody | Bovine |
GM-Tg-equg-T88023-Ab-1/ GM-Tg-equg-T88023-Ab-2 | Anti-Equine TNFRSF8 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T88023-Ab-1/ GM-Tg-hg-T88023-Ab-2; GM-Tg-rg-T88023-Ab-1/ GM-Tg-rg-T88023-Ab-2; GM-Tg-mg-T88023-Ab-1/ GM-Tg-mg-T88023-Ab-2; GM-Tg-cynog-T88023-Ab-1/ GM-Tg-cynog-T88023-Ab-2; GM-Tg-felg-T88023-Ab-1/ GM-Tg-felg-T88023-Ab-2; GM-Tg-cang-T88023-Ab-1/ GM-Tg-cang-T88023-Ab-2; GM-Tg-bovg-T88023-Ab-1/ GM-Tg-bovg-T88023-Ab-2; GM-Tg-equg-T88023-Ab-1/ GM-Tg-equg-T88023-Ab-2 |
Products Name | Anti-TNFRSF8 monoclonal antibody |
Format | mab |
Target Name | TNFRSF8 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-TNFRSF8 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Biosimilar | GMP-Bios-INN-765 | Pre-Made Brentuximab Vedotin Biosimilar, Whole Mab Adc, Anti-Tnfrsf8 Antibody: Anti-CD30/D1S166E/Ki-1 therapeutic antibody Drug Conjugate |
Biosimilar | GMP-Bios-ab-080 | Pre-Made Brentuximab biosimilar, Whole mAb ADC, Anti-TNFRSF8 Antibody: Anti-CD30/Ki-1/D1S166E therapeutic antibody |
Biosimilar | GMP-Bios-ab-278 | Pre-Made Iratumumab biosimilar, Whole mAb, Anti-TNFRSF8 Antibody: Anti-CD30/Ki-1/D1S166E therapeutic antibody |
Target Antigen | Products Developing | Multi-species TNR8/ TNFRSF8/ CD30 VLP (virus-like particle) (Products Developing) |
Cytokine | GM-Tg-g-T88023-Ag-1 | tumor necrosis factor receptor superfamily, member 8 (TNFRSF8) protein |
ORF Viral Vector | pGMLPm004985 | mouse Tnfrsf8 Lentivirus plasmid |
ORF Viral Vector | vGMLPm004985 | mouse Tnfrsf8 Lentivirus particle |
Target information
Target ID | GM-T88023 |
Target Name | TNFRSF8 |
Gene ID | 943,21941,25069,722773,487438,101101575,614780,100055885 |
Gene Symbol and Synonyms | CD30,D1S166E,Ki,Ki-1,TNFRSF8 |
Uniprot Accession | P28908,P97525 |
Uniprot Entry Name | TNR8_HUMAN,TNR8_RAT |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target, Immuno-oncology Target, INN Index, Cytokine Target |
Disease | Cancer |
Gene Ensembl | ENSG00000120949 |
Target Classification | Checkpoint-Immuno Oncology, Tumor-associated antigen (TAA) |
The target: TNFRSF8, gene name: TNFRSF8, also named as CD30, D1S166E, Ki-1. The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed by activated, but not by resting, T and B cells. TRAF2 and TRAF5 can interact with this receptor, and mediate the signal transduction that leads to the activation of NF-kappaB. This receptor is a positive regulator of apoptosis, and also has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.